bullish
Indegene Limited Pre-IPO: Subscribe on Profitable Niche Business Model and Attractive Valuation
Tina has highlighted this Insight as a Top Pick
973 Views29 Apr 2024 15:23
SUMMARY
- Indegene Limited (1864095D IN) has set IPO price band at INR430–452 per share. The IPO consists of fresh issue as well as OFS by existing shareholders.
- Considering FY24 annualized post-IPO EPS of INR13.48, Indegene seeks a P/E valuation of 31.9–33.5x.
- Considering niche business focus, proven execution capability, marquee clientele, long-standing client relationship, life science focus, and comprehensive offering, Indegene’s valuation seems quite attractive.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Indegene Lockup Expiry - US$1bn+ Lockup Release, Some Could Look to Book 3x Gain31 Oct 2024
- Indegene IPO Trading - High Anchor Quality + Strong Demand, Expect a Pop on Debut10 May 2024
- Indegene IPO - Marquee Clients, Strong Track Record, Decent Valuation03 May 2024
- Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth19 Apr 2023
- Indegene Limited (1864095D IN) Pre-IPO: Enough Head Room For Long-Term Profitable Growth13 Apr 2023
- Indegene Pre-IPO Tearsheet22 Dec 2022
x